1. Home
  2. VVOS vs AIDX Comparison

VVOS vs AIDX Comparison

Compare VVOS & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$0.43

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$0.60

Market Cap

9.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VVOS
AIDX
Founded
2016
N/A
Country
United States
United States
Employees
N/A
14
Industry
Medical Specialities
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7M
9.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
VVOS
AIDX
Price
$0.43
$0.60
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$2.75
N/A
AVG Volume (30 Days)
487.8K
454.5K
Earning Date
04-15-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
6.76
N/A
EPS
N/A
N/A
Revenue
$17,443,000.00
N/A
Revenue This Year
$69.66
N/A
Revenue Next Year
$48.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.05
N/A
52 Week Low
$0.38
$0.51
52 Week High
$7.40
$14.09

Technical Indicators

Market Signals
Indicator
VVOS
AIDX
Relative Strength Index (RSI) 37.87 36.13
Support Level $0.38 $0.52
Resistance Level $0.55 $0.70
Average True Range (ATR) 0.06 0.06
MACD 0.01 0.03
Stochastic Oscillator 31.76 41.45

Price Performance

Historical Comparison
VVOS
AIDX

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: